|
|
基于LPS/TLR4/NF-κB信号通路探讨中药干预糖尿病慢性炎症状态研究进展
|
Abstract:
随着高脂饮食、运动量减少等不良生活习惯的形成，糖尿病患者数量与日俱增，已成为全球严重的公共卫生问题，为缓解社会经济负担和医疗压力，探析糖尿病的有效治疗手段和抑制恶化一直是目前的首要主攻方向。近年来研究显示，肠道菌群失调与糖尿病的发生发展密切相关，其通过诱发体内代谢性内毒素血症、胆汁酸代谢紊乱和短链脂肪酸(SCFA)生成减少等机制导致糖尿病的病理过程发生，其中尤以LPS/TLR4/NF-κB信号通路与糖尿病的慢性炎症状态和胰岛素抵抗(IR)的发生关联密切。中医药一直被运用于糖尿病的治疗，临床及动物实验疗效显著，且不良反应小，目前关于中医药的活性成分及中医药复方通过抑制LPS/TLR4/NF-κB信号通路中的炎症因子分泌，阻断糖尿病持续慢性炎症损伤，调节IR，改善糖尿病症状的研究十分广泛，以此为切入点通过对近年来中医药的活性成分及中医药复方抑制LPS/TLR4/NF-κB信号通路治疗糖尿病慢性炎症状态的研究进展做一简要综述，以期为糖尿病的防治药物及治疗方法探究提供有力证据支持。
With the formation of poor lifestyle habits such as high-fat diet and reduced exercise, the number of diabetes patients is increasing day by day and has become a serious public health problem world-wide. To alleviate the social and economic burden and medical pressure, exploring effective treat-ments for diabetes and inhibiting its deterioration has been the primary main focus at present. Re-cent studies have shown that dysbiosis of intestinal flora is closely related to the development of diabetes, which leads to the pathological process of diabetes by inducing metabolic endotoxemia, disturbance of bile acid metabolism and reduction of short-chain fatty acid (SCFA) production in vi-vo, among which the LPS/TLR4/NF-κB signaling pathway is closely associated with the chronic in-flammatory state and the development of insulin resistance (IR) in diabetes. Chinese medicine has been used in the treatment of diabetes mellitus, with significant efficacy and low adverse effects in clinical and animal experiments. Currently, there is extensive research on the active ingredients of Chinese medicine and Chinese medicine compound to block the continuous chronic inflammatory damage in diabetes mellitus, regulate IR and improve the symptoms of diabetes mellitus by inhib-iting the secretion of inflammatory factors in LPS/TLR4/NF-κB signaling pathway. This is the start-ing point for a brief review of the recent research progress on the active ingredients of TCM and TCM compound to inhibit LPS/TLR4/NF-κB signaling pathway in the treatment of chronic inflammatory state of diabetes mellitus, in order to provide strong evidence to support the investigation of drugs and treatment methods for diabetes mellitus.
| [1] | Wu, Y., Ding, Y., Tanaka, Y. and Zhang, W. (2014) Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention. International Journal of Medical Sciences, 11, 1185-200.
https://doi.org/10.7150/ijms.10001 |
| [2] | Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Di-abetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federa-tion Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843 |
| [3] | Gutiérrez-Salmerón, M., Lucena, S.R., Chocarro-Calvo, A., et al. (2021) Remodelling of Colorectal Cancer Cell Signalling by Microbiota and Immunity in Diabetes. Endocrine-Related Cancer, 28, R173-R190.
https://doi.org/10.1530/ERC-20-0315 |
| [4] | Chen, D., Jin, D., Huang, S., Wu, J., Xu, M., Liu, T., Dong, W., Liu, X., Wang, S., Zhong, W., et al. (2020) Clostridium butyricum, a Butyrate-Producing Probiotic, Inhibits Intestinal Tumor Development through Modulating Wnt Signaling and Gut Microbiota. Cancer Letters, 469, 456-467. https://doi.org/10.1016/j.canlet.2019.11.019 |
| [5] | Amyot, J., Semache, M., Ferdaoussi, M., Fontés, G. and Poitout, V. (2012) Lipopolysaccharides Impair Insulin Gene Expression in Isolated Islets of Langerhans via Toll-Like Receptor-4 and NF-κB Signalling. PLOS ONE, 7, e36200.
https://doi.org/10.1371/journal.pone.0036200 |
| [6] | 杨玥, 吴晓康. 中医药干预肠道菌群防治糖尿病的研究进展[J]. 中国实验方剂学杂志, 2021, 27(7): 219-227. |
| [7] | Pitt, J.M., Vétizou, M., Gomperts Boneca, I., et al. (2016) En-hancing the Clinical Coverage and Anticancer Efficacy of Immune Checkpoint Blockade through Manipulation of the Gut Microbiota. OncoImmunology, 6, e1132137.
https://doi.org/10.1080/2162402X.2015.1132137 |
| [8] | Kim, K.-A., Gu, W., Lee, I.-A., Joh, E.-H. and Kim, D.-H. (2012) High Fat Diet-Signaling Pathway. PLOS ONE, 7, e47713. https://doi.org/10.1371/journal.pone.0047713 |
| [9] | Wisniewski, P.J., Dowden, R.A. and Campbell, S.C. (2019) Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota. Nutrients, 11, Article No. 117. https://doi.org/10.3390/nu11010117 |
| [10] | Jia, L., Vianna, C., Fukuda, M., et al. (2014) Hepatocyte Toll-Like Re-ceptor 4 Regulates Obesity-Induced Inflammation and Insulin Resistance. Nature Communications, 5, Article No. 3878. https://doi.org/10.1038/ncomms4878 |
| [11] | 陈洁, 姜虹. TLR4 信号通路与炎性反应[J]. 医学综述, 2009, 15(19): 2902-2904. |
| [12] | Ryu, J.-K., Kim, S.J., Rah, S.-H., et al. (2017) Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer. Immunity, 46, 38-50.
https://doi.org/10.1016/j.immuni.2016.11.007 |
| [13] | Akash, M.S.H., Rehman, K. and Liaqat, A. (2018) Tumor Ne-crosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus. Journal of Cellular Biochemistry, 119, 105-110.
https://doi.org/10.1002/jcb.26174 |
| [14] | Ueki, K., Kondo, T. and Kahn, C.R. (2004) Suppressor of Cytokine Signal-ing 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Re-ceptor Substrate Proteins by Discrete Mechanisms. Molecular and Cellular Biology, 24, 5434-5446. https://doi.org/10.1128/MCB.24.12.5434-5446.2004 |
| [15] | Ahmed, B., Sultana, R. and Greene, M.W. (2021) Adi-pose Tissue and Insulin Resistance in Obese. Biomedicine & Pharmacotherapy, 137, Article ID: 111315. https://doi.org/10.1016/j.biopha.2021.111315 |
| [16] | Khondkaryan, L., Margaryan, S., Poghosyan, D., et al. (2018) Impaired Inflammatory Response to LPS in Type 2 Diabetes Mellitus. International Journal of Inflammation, 2018, Ar-ticle ID: 2157434.
https://doi.org/10.1155/2018/2157434 |
| [17] | Huang, J., Guan, B., Lin, L., et al. (2021) Improvement of Intestinal Barrier Function, Gut Microbiota, and Metabolic Endotoxemia in Type 2 Diabetes Rats by Curcumin. Bioengineered, 12, 11947-11958.
https://doi.org/10.1080/21655979.2021.2009322 |
| [18] | Gu, W., Wang, Y., Zeng, L., et al. (2020) Polysaccharides From Polygonatum kingianum Improve Glucose and Lipid Metabolism in Rats Fed a High Fat Diet. Biomedicine & Pharmacotherapy, 125, Article ID: 109910.
https://doi.org/10.1016/j.biopha.2020.109910 |
| [19] | Zhang, W., Xu, J.-H., Yu, T. and Chen, Q.-K. (2019) Effects of Berberine and Metformin on Intestinal Inflammation and Gut Microbiome Composition in db/db Mice. Biomedicine & Pharmacotherapy, 118, Article ID: 109131.
https://doi.org/10.1016/j.biopha.2019.109131 |
| [20] | Duan, Y., Dai, H., An, Y., et al. (2022) Mulberry Leaf Flavo-noids Inhibit Liver Inflammation in Type 2 Diabetes Rats by Regulating TLR4/MyD88/NF-κB Signaling Pathway. Evi-dence-Based Complementary and Alternative Medicine, 2022, Article ID: 3354062. https://doi.org/10.1155/2022/3354062 |
| [21] | 朱金华, 周军, 万红娇, 等. 黄连温胆汤对 2 型糖尿病模型大鼠细胞因子及TLR4、NF-κB变化的影响[J]. 中药药理与临床, 2021, 37(3): 6-11. |
| [22] | 章常华, 马广强, 邓永兵, 等. 葛根芩连汤对KK-Ay糖尿病小鼠血浆中LPS、TNF-α、IL-6及肠道菌群的影响[J]. 中草药, 2017, 48(8): 1611-1616. |
| [23] | 吴帆. 乌梅丸调节肠道菌群对2型糖尿病的干预作用及机制研究[D]: [硕士学位论文]. 南昌: 江西中医药大学, 2019. |
| [24] | 陈玲玲, 张思为, 李董平, 陈伊莉. 薏苡附子败酱散对糖尿病小鼠炎症因子及肠道菌群的影响[J]. 陕西中医, 2018, 39(4): 415-418. |
| [25] | 池杨峰, 刘爽, 黄洁波, 等. 黄芪汤通过TLR4/NF-κB信号通路改善糖尿病肾病大鼠炎症反应的研究[J]. 临床肾脏病杂志, 2022, 22(1): 39-45. |
| [26] | 李志俊. 黄芪汤通过抑制TLR4/NF-κB信号通路改善糖尿病肾病大鼠的炎症反应[D]: [硕士学位论文]. 上海: 上海中医药大学, 2019. https://doi.org/10.27320/d.cnki.gszyu.2019.000774 |
| [27] | 张岩. 泻火解毒养阴方对2型糖尿病小鼠LPS/TLR4/NF-κB信号通路的影响[D]: [硕士学位论文]. 济南: 山东中医药大学, 2020. |
| [28] | Li, M., Ding, L., Hu, Y.-L., et al. (2021) Herbal Formula LLKL Ameliorates Hyperglycaemia, Modulates the Gut Microbiota and Regulates the Gut-Liver Axis in Zucker Diabetic Fatty Rats. Journal of Cellular and Molecular Medicine, 25, 367-382. https://doi.org/10.1111/jcmm.16084 |
| [29] | 刘文娟, 乐世俊, 姬玉洁, 等. 中药多糖调节肠道菌群治疗2型糖尿病研究进展[J]. 陕西中医药大学学报, 2023, 46(2): 36-42. |
